NeoproPain
NeoPro Pain has discovered an analgesic that is a new molecular entity for postoperative pain. It is neither an opioid nor a NSAID.
- Stage Product In Development
- Industry Biotechnology
- Location Seattle, WA, USA
- Currency USD
- Founded October 2005
- Employees 2
- Website neoprolabs.com
Company Summary
NeoPro Pain Inc. (NPP) is a biotech company poised to capitalize on the founder discovery of analgesic compounds. NPP, a Washington corporation, was founded by Dr. Hanna Skubatch and Mr. Haim Ben Skubatch in 2005. NPP believes that its discoveries have the potential to create the next generation of analgesics. NPP technology is protected by USA patents and international patents.
Team
-
CEO
Hanna Skubatch is the inventor of NPP-1. She holds a Ph.D. in Life Sciences, Bar-Ilan University, Israel. She was a research faculty at the Botany, Dept., University of Washington, Seattle. Hanna brings over 30 years of experience in life sciences with numerous scientific publications and patents.
Advisors
-
Wilson Sonsini Goodrich &RosatiPatents and regulationUnconfirmed
Previous Investors
-
Ben SkubatchCo-founderUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.